Amgen Inc (AMGN)
262.65
-0.53
(-0.20%)
USD |
NASDAQ |
Dec 27, 16:00
262.80
+0.15
(+0.06%)
After-Hours: 20:00
Amgen SG&A Expense (Quarterly): 1.625B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly and Co | 2.100B |
| Merck & Co Inc | 2.731B |
| Pfizer Inc | 3.244B |
| Regeneron Pharmaceuticals Inc | 714.40M |
| Viking Therapeutics Inc | 13.77M |